The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression
about
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsRHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stabilityRecent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelThe roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progressionRHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activityInterplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motilitySmall activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancerRHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.Prestige centrality-based functional outlier detection in gene expression analysis.Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.Prognostic impact of CD168 expression in gastric cancer.Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON.Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function.EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantationBub1 is required for maintaining cancer stem cells in breast cancer cell linesUpregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival.RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small intestinal submucosa-augmented rat bladder regeneration model.Improved biochemical strategies for targeted delivery of taxoidsApplications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatmentTwo-marker protein profile predicts poor prognosis in patients with early rectal cancerRHAMM Expression in the Rat Endometrium during the Estrous Cycle and following ImplantationHyaluronan and hyaluronidase in genitourinary tumors.Prognostic significance of CD168 overexpression in colorectal cancerHyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.RB Loss Promotes Prostate Cancer Metastasis.Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal AdenocarcinomaCarcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.Synergistic effect of interleukin-6 and hyaluronic acid on cell migration and ERK activation in human keratinocytes.The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells
P2860
Q24595836-062D7B5A-CC94-4F80-9AF6-5F88E694FD48Q24680197-D282A918-394F-435A-B353-235DC17AFA25Q27010654-7D5211D6-185D-4108-AADC-9FC28FF66DC1Q27025313-8EBAE04D-EE2C-41F0-9B5C-8A29586778F2Q28285641-36A1486A-448A-4122-A224-E078C0C9C18EQ28304661-547AF45C-0593-48D4-95C3-3BB56DD5079BQ28539229-185EF174-FEA0-4990-9D8F-F2A708F90F2EQ33499385-5FA85D9C-72A9-4CE6-9580-D4EBB9D2AC5CQ33567049-37418296-4BD2-497C-91FF-9EE2FA118614Q33674704-9B08E9B3-A74C-4545-AC85-7A03ED469E84Q33760690-E7711A25-8945-410C-87FA-AD0E9F01C8A7Q33842800-04EDE80C-9617-4BDF-965B-7A656DB80447Q33854876-AA5A5AC2-CA70-40A4-8509-E114B78C6916Q34003991-B77DA9D9-14BB-4074-BE17-EB74830F84F3Q34578204-20272972-C207-4D7B-B4F3-ED7F9D6B0C5FQ35745456-FE4A1684-B92F-47A5-B5FB-C2A3444FF878Q35773975-6AEA899C-F203-42EF-8CC3-BC8C985E1902Q35875956-622D7C4A-E408-4E35-8EED-73DF112E3827Q36032008-A5A1E085-3A46-4AA6-BD53-1710837A92C6Q36237801-BD4C2FFE-26B8-450F-AF7B-F69973AD7A3EQ36334849-CB6710E1-ED87-4C7C-8998-D3F5D5B74696Q36366953-C7BF10D6-22ED-448B-8ABE-45DA50D14B4CQ36425954-66603F2C-5F1D-46AB-96AF-42C06F4090C6Q36642502-47A38C8C-4B40-4527-8177-A2EE6BDD2083Q36893273-28EFE21C-8B3D-4FC9-B76D-257D759C0AF6Q36977547-DD03B6E1-C3E0-4A98-A993-6157DAE3817BQ37035328-F402503D-1104-4F20-B82F-F03445BCDA65Q37072219-99C9E0C8-F60D-455C-A9E2-78E485AE7B25Q37287615-F95F256B-294D-4E01-9566-09687B8F1FACQ37461694-344E1BAE-AE3B-485E-9576-1371322E5895Q37467189-E5944257-9249-437F-9461-ADFD1EB11A50Q37683868-764F85E3-2C25-45A4-91D6-81F93B2AF4AFQ38243335-04AC5288-EE0B-48D8-8673-D3B85F165547Q38631638-9FEB3BAE-FF62-409E-A9B0-C5B582CD94DAQ38727367-FDA3564B-D436-4A2E-9FE0-3CDF4EA0FE83Q38823693-6512EA4E-EA26-4FEB-B960-33ADEA3AE3B2Q38838567-5BC47060-DBEA-46A3-88B2-F8F32E600B5EQ38927595-82BEE032-29BD-48FC-8BFD-C56C3717C765Q38932350-BD697F7A-903C-4467-8B50-DC5352405AE6Q39360428-BBF62ED4-C1AE-4ECC-B49E-FBAC5480F5A6
P2860
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The overexpression of RHAMM, a ...... r in breast cancer progression
@ast
The overexpression of RHAMM, a ...... r in breast cancer progression
@en
The overexpression of RHAMM, a ...... r in breast cancer progression
@nl
type
label
The overexpression of RHAMM, a ...... r in breast cancer progression
@ast
The overexpression of RHAMM, a ...... r in breast cancer progression
@en
The overexpression of RHAMM, a ...... r in breast cancer progression
@nl
prefLabel
The overexpression of RHAMM, a ...... r in breast cancer progression
@ast
The overexpression of RHAMM, a ...... r in breast cancer progression
@en
The overexpression of RHAMM, a ...... r in breast cancer progression
@nl
P2093
P3181
P1476
The overexpression of RHAMM, a ...... r in breast cancer progression
@en
P2093
E A Turley
P H Watson
R Kerschmann
P304
P3181
P407
P577
1998-03-01T00:00:00Z